Collplant Holdings (CLGN)

Collplant Holdings Stock Price & Analysis


CLGN Stock Chart & Stats

Day’s Range$0 - $0
52-Week Range$6.18 - $23.00
Previous Close$6.8
Average Volume (3M)18.18K
Market CapN/A
Enterprise ValueN/A
Total Cash (Recent Filing)$3.33M
Total Debt (Recent Filing)$2.97M
P/E Ratio-4.9
Next EarningsDec 02, 2022
Next Dividend Ex-DateN/A
Dividend YieldN/A
1Y Price TargetN/A
EPS (TTM)-1.39
Shares Outstanding9,914,740
Standard Deviation0.16
10 Day Avg. Volume17,340
30 Day Avg. Volume18,182
P/B Ratio4.40
P/S Ratio152.53
P/CF Ratio15.50
P/FCF Ratio-16.10
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/EbitdaN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0



P/E Ratio Range

The price to earnings ratio. This is used by investors to assess a stock’s market price relative to its earnings.


Risk Analysis

Main Risk Category
Tech & InnovationRisks related to the company’s reliance on technology and ability to make innovative products

Product Monthly Users

Sorry, No Data Available
There is no website visitor data available for this stock.



What was Collplant Holdings’s price range in the past 12 months?
Collplant Holdings lowest stock price was $6.18 and its highest was $23.00 in the past 12 months.
    What is Collplant Holdings’s market cap?
    Currently, no data Available
    When is Collplant Holdings’s upcoming earnings report date?
    Collplant Holdings’s upcoming earnings report date is Dec 02, 2022 which is in 59 days.
      How were Collplant Holdings’s earnings last quarter?
      Collplant Holdings released its earnings results on Aug 25, 2022. The company reported -$0.39 earnings per share for the quarter, missing the consensus estimate of -$0.08 by -$0.31.
        Is Collplant Holdings overvalued?
        According to Wall Street analysts Collplant Holdings’s price is currently Overvalued. Get more investment ideas with TipRanks Premium
          Does Collplant Holdings pay dividends?
          Collplant Holdings does not currently pay dividends.
          What is Collplant Holdings’s EPS estimate?
          Collplant Holdings’s EPS estimate is -$0.31.
            How many shares outstanding does Collplant Holdings have?
            Collplant Holdings has 11,011,481 shares outstanding.
              What happened to Collplant Holdings’s price movement after its last earnings report?
              Collplant Holdings reported an EPS of -$0.39 in its last earnings report, missing expectations of -$0.08. Following the earnings report the stock price went down -0.248%.
                Which hedge fund is a major shareholder of Collplant Holdings?
                Among the largest hedge funds holding Collplant Holdings’s share is ARK Investment Management LLC. It holds Collplant Holdings’s shares valued at 2M.


                  Collplant Holdings Stock Analysis

                  Smart ScoreNeutral
                  The Collplant Holdings stock analysis is based on the TipRanks Smart Score which is derived from 8 unique data sets including Analyst recommendations, Crowd Wisdom, Hedge Fund Activity, Media Sentiment and multiple Technical stock factors. The Smart Score is a quantitative, data-driven rating system and does not include human intervention.
                  Learn more about TipRanks Smart Score

                  Company Description

                  Collplant Holdings

                  CollPlant Biotechnologies Ltd. is a regenerative medicine company. It engages in the research, development, manufacture and marketing of medical products for tissue repair, initially for orthobiologics and advanced wound care markets. The company's products include VergenixSTR, VergenixFG, CollPlant Surgical Matrix. Collplant Holdings was founded by in June 2004 and is headquartered in Ness-Ziona, Israel.

                  Similar Stocks
                  Price & Change
                  Urogen Pharma
                  Gamida Cell
                  Enlivex Therapeutics

                  Popular Stocks

                  What's Included in PREMIUM?
                  Make informed decisions based on Top Analysts' activity
                  Know what industry insiders are buying
                  Get actionable alerts from top Wall Street Analysts
                  Find out before anyone else which stock is going to shoot up
                  Get powerful stock screeners & detailed portfolio analysis